These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24347326)

  • 41. X-ray crystal structure of aristolochene synthase from Aspergillus terreus and evolution of templates for the cyclization of farnesyl diphosphate.
    Shishova EY; Di Costanzo L; Cane DE; Christianson DW
    Biochemistry; 2007 Feb; 46(7):1941-51. PubMed ID: 17261032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MALDI-MS Analysis of Peptide Libraries Expands the Scope of Substrates for Farnesyltransferase.
    Schey GL; Buttery PH; Hildebrandt ER; Novak SX; Schmidt WK; Hougland JL; Distefano MD
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation.
    Pickett JS; Bowers KE; Hartman HL; Fu HW; Embry AC; Casey PJ; Fierke CA
    Biochemistry; 2003 Aug; 42(32):9741-8. PubMed ID: 12911316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Context-dependent substrate recognition by protein farnesyltransferase.
    Hougland JL; Lamphear CL; Scott SA; Gibbs RA; Fierke CA
    Biochemistry; 2009 Mar; 48(8):1691-701. PubMed ID: 19199818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural insights into the antifungal drug target guanosine monophosphate synthase from Aspergillus fumigatus.
    Nguyen S; Jovcevski B; Pukala TL; Bruning JB
    Acta Crystallogr D Struct Biol; 2022 Feb; 78(Pt 2):248-259. PubMed ID: 35102890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photoactive analogs of farnesyl diphosphate and related isoprenoids: design and applications in studies of medicinally important isoprenoid-utilizing enzymes.
    Vervacke JS; Wang YC; Distefano MD
    Curr Med Chem; 2013; 20(12):1585-94. PubMed ID: 23409719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
    Reid TS; Terry KL; Casey PJ; Beese LS
    J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photoaffinity analogues of farnesyl pyrophosphate transferable by protein farnesyl transferase.
    Chehade KA; Kiegiel K; Isaacs RJ; Pickett JS; Bowers KE; Fierke CA; Andres DA; Spielmann HP
    J Am Chem Soc; 2002 Jul; 124(28):8206-19. PubMed ID: 12105898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystallographic snapshots of Aspergillus fumigatus phytase, revealing its enzymatic dynamics.
    Liu Q; Huang Q; Lei XG; Hao Q
    Structure; 2004 Sep; 12(9):1575-83. PubMed ID: 15341723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein farnesyltransferase inhibitors.
    Ayral-Kaloustian S; Salaski EJ
    Curr Med Chem; 2002 May; 9(10):1003-32. PubMed ID: 12733981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.
    Long SB; Hancock PJ; Kral AM; Hellinga HW; Beese LS
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12948-53. PubMed ID: 11687658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural and kinetic differences between human and Aspergillus fumigatus D-glucosamine-6-phosphate N-acetyltransferase.
    Hurtado-Guerrero R; Raimi OG; Min J; Zeng H; Vallius L; Shepherd S; Ibrahim AF; Wu H; Plotnikov AN; van Aalten DM
    Biochem J; 2008 Oct; 415(2):217-23. PubMed ID: 18601654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures.
    Long SB; Casey PJ; Beese LS
    Structure; 2000 Feb; 8(2):209-22. PubMed ID: 10673434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem.
    Sousa SF; Fernandes PA; Ramos MJ
    Curr Med Chem; 2008; 15(15):1478-92. PubMed ID: 18537624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
    Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of N-myristoyltransferase from Aspergillus fumigatus.
    Shimada T; Suzuki M; Katakura S
    Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):754-61. PubMed ID: 25849386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Library Screening, In Vivo Confirmation, and Structural and Bioinformatic Analysis of Pentapeptide Sequences as Substrates for Protein Farnesyltransferase.
    Schey GL; Hildebrandt ER; Wang Y; Diwan S; Passetti HA; Potts GW; Sprague-Getsy AM; Leoni ER; Kuebler TS; Sham YY; Hougland JL; Beese LS; Schmidt WK; Distefano MD
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and structural validation of Aspergillus fumigatus N-acetylphosphoglucosamine mutase as an antifungal target.
    Fang W; Du T; Raimi OG; Hurtado-Guerrero R; Mariño K; Ibrahim AF; Albarbarawi O; Ferguson MA; Jin C; Van Aalten DM
    Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23844980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
    Alcazar-Fuoli L; Cuesta I; Rodriguez-Tudela JL; Cuenca-Estrella M; Sanglard D; Mellado E
    Int J Antimicrob Agents; 2011 Nov; 38(5):426-34. PubMed ID: 21871783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.